Cytopeutics is proud to announce that Prof. Dr Chin has been honourably invited as speaker at the conference of Asia Federation of Biotechnology (10 July 2021) on the use of MSC for post-Covid 19 lung inflammation and fibrosis. In his presentation, he has given great insights on the anti-inflammatory and immunomodulatory actions of human umbilicord derived mesenchymal stem cells on a clinical perspective.
It is the first international academic forum in Asia to discuss the clinical practice of MSC therapy for COVID-19 treatment, drawing experience from more than 50 cases. Key scholars from six Asian countries, including Indonesia, Japan, Malaysia, Singapore, Thailand and Taiwan, has joined together to share their personal experience and valuable intuitions.
It is the first international academic forum in Asia to discuss the clinical practice of MSC therapy for COVID-19 treatment, drawing experience from more than 50 cases. Key scholars from six Asian countries, including Indonesia, Japan, Malaysia, Singapore, Thailand and Taiwan, has joined together to share their personal experience and valuable intuitions.
